Vitamin D Reverts Resistance to the mTOR Inhibitor Everolimus in Hepatocellular Carcinoma Through the Activation of a miR-375/oncogenes Circuit

Scientific Reports - United Kingdom
doi 10.1038/s41598-019-48081-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Potential Role of Vitamin D in Restoring Sensitivity to mTOR Inhibitors in Hepatocellular Carcinoma (HCC): 1,25(OH)vitamin D (VITD) Reverts Everolimus (EVE) Resistance in a HCC Cell Line

Endocrine Abstracts
2016English

MiR-122 Reverses the Doxorubicin-Resistance in Hepatocellular Carcinoma Cells Through Regulating the Tumor Metabolism

PLoS ONE
Multidisciplinary
2016English

Potentiation of the Anticancer Effects of Everolimus Using a Dual mTORC1/2 Inhibitor in Hepatocellular Carcinoma Cells

Oncotarget
Oncology
2016English

Β1 Integrin-Mediated Multicellular Resistance in Hepatocellular Carcinoma Through Activation of the FAK/Akt Pathway

Journal of International Medical Research
BiochemistryMedicineCell Biology
2018English

In Hepatocellular Carcinoma miR-221 Modulates Sorafenib Resistance Through Inhibition of Caspase-3–Mediated Apoptosis

Clinical Cancer Research
Cancer ResearchOncology
2017English

Chromosome 1q21 Amplification and Oncogenes in Hepatocellular Carcinoma

Acta Pharmacologica Sinica
MedicinePharmacology
2010English

Persistent Activation of Nrf2 Through P62 in Hepatocellular Carcinoma Cells

Journal of Cell Biology
MedicineCell Biology
2011English

Antitumor Effect of Sorafenib and mTOR Inhibitor in Liver Transplantation Recipients With Hepatocellular Carcinoma Recurrence

Liver Transplantation
HepatologyTransplantationSurgery
2018English

Circulating AIM Prevents Hepatocellular Carcinoma Through Complement Activation

Cell Reports
BiochemistryGeneticsMolecular Biology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy